ATP Barcelona 2017

Heart

Quantec: „old“ tolerance dose for clinically relevant endpoints 40 Gy/ 2 Gy ? Darby (breast cancer patients): no threshold

7%/Gy increased risk AB survivors registry: increasing risk for CAD from mSv doses Treatment: symptomatic